Compare Tenet Healthcare Corporation (THC) vs Vanguard Tax Managed Fund FTSE Developed Markets ETF (VEA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Vanguard Tax Managed Fund FTSE Developed Markets ETF — how do they compare? Tenet Healthcare Corporation trades at $263.78 (market cap $20.98B), while Vanguard Tax Managed Fund FTSE Developed Markets ETF trades at $70.35 (market cap $323.80B). The key difference: Vanguard Tax Managed Fund FTSE Developed Markets ETF is far larger — about 15.4× Tenet Healthcare Corporation's market cap, and Tenet Healthcare Corporation is more actively traded (428,008 versus 17,001,112). Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Vanguard Tax Managed Fund FTSE Developed Markets ETF for 131 Days on average.
| THC | VEA | |
|---|---|---|
Market Cap | $20.98B | $323.80B |
Volume | 428,008 | 17,001,112 |
Sector | Health | — |
52-Week High | $280.77 | $73.79 |
52-Week Low | $161.37 | $58.90 |
Typical Hold Time | 15 Days | 131 Days |
Enterprise Value | $32.06B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $263.78, up 1.52% today, with a bullish technical signal from moving averages and strong fundamental support. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 29, 2026. Revenue grew to $21.31B in 2025, with a robust net income margin of 9.9% and high return on equity of 53.31%, while valuation ratios like P/E of 10.07 and EV/EBITDA of 5.75 suggest potential undervaluation.
The outlook is positive, driven by earnings momentum and analyst consensus favoring buys, with a price target of $283.36 offering upside. Risks include reliance on surgical volumes and capital return sustainability, but strong cash flow and efficiency gains support growth. Investors should weigh solid fundamentals against sector-specific headwinds.
VEA trades at $69.86, down 0.57% on the day, with a bearish technical signal from moving averages and oscillators. The ETF's low expense ratio of 0.03% and focus on developed markets outside the U.S. are key attributes, though financial ratios are not disclosed in the provided data. Recent news highlights institutional activity, with firms like Allianz Asset Management increasing positions while others reduced stakes.
The outlook for VEA is mixed, with technical indicators suggesting near-term pressure, but its cost efficiency and dividend yield offer long-term value. Risks include market volatility and economic shifts in developed economies. Investors should weigh the bearish technicals against the fund's structural advantages in a diversified portfolio.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Vanguard Tax Managed Fund FTSE Developed Markets ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex US Index, a market-capitalization-weighted index that is made up of approximately 4022 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VEA →
